֍ Cancer Molecular Tests
֍ Cordis DX® Tests
֍ Cerebrum DX® Tests
֍ MyTheragene® Test
The RediScore® test is recommended primarily in all patients with ovarian cancer, but also where PARP inhibitor therapy is under investigation for treatment or maintenance of the patient.